Patients at high risk for ischemic stroke: identification and actions

Area of Science:

• Cardiovascular Medicine
• Inflammatory Diseases
• Vascular Biology

Background:

• Atherosclerosis is a chronic, multisystem inflammatory disease affecting vascular, metabolic, and immune systems.
• Current risk evaluation relies on clinical, biological, and imaging assessments, which are insufficient for predicting near-future vascular events.
• Symptomatic disease burden is a critical predictor of recurrent major vascular events.

Purpose of the Study:

• To highlight the limitations of traditional atherosclerosis risk assessment.
• To emphasize the importance of managing modifiable risk factors like hypertension and dyslipidemia.
• To advocate for the integration of novel markers and techniques for individualized intervention.

Main Methods:

• Review of existing clinical, biological, and imaging assessment methods for atherosclerosis.
• Analysis of the impact of modifiable risk factors (hypertension, dyslipidemia, atrial fibrillation, lifestyle factors) on stroke incidence.
• Discussion on the need for advanced systemic markers and investigation techniques.

Main Results:

• Traditional methods inadequately predict near-future vascular events in standard clinical practice.
• Active treatment of hypertension is a highly efficient measure to reduce stroke incidence.
• Lifestyle factors significantly contribute to the high incidence of stroke.

Conclusions:

• There is a critical need for improved methods to identify individuals at high risk for atherosclerosis.
• More aggressive management of modifiable risk factors, particularly hypertension, is essential.
• Future strategies should incorporate new systemic markers and investigation techniques for individualized therapies.